I can only imagine those suffering from post-traumatic stress disorder (PTSD) are reading news that the Food and Drug Administration (FDA) has approved the use of MDMA (ecstasy) in large-scale trials.
The new Phase 3 research will see 230 patients involved, funded by Multidisciplinary Association for Psychedelic Studies (MAPS), an organization that pushes for the medical use of marijuana, LSD, and MDMA. MAPS funded the Phase 2 studies of MDMA with 130 PTSD patients. One study showed that out of 19 patients, 56% said that their PTSD symptoms weren't as strong after taking ecstasy with just three doses of MDMA - by the end of the study, two-thirds of them no longer met the criteria required for having PTSD - impressive.
Andrew Parrott, a psychologist at Swansea University in Wales said: "It sends the message that this drug will help you solve your problems, when often it just creates problems. This is a messy drug we know can do damage". But it's not as cut and dry as that, with a C.J. Hardin - a veteran who did three tours in Afghanistan and Iraq, said: "I just felt hopeless and in the dark. But the MDMA sessions showed me a light I could move toward. Now I'm out of the darkness and the world is all around me".
At the end of the day, if they're not hurting anyone by taking MDMA in their own homes - to deal with the heavy symptoms of PTSD, then why the hell stop them? I have the same thoughts on medical marijuana use - there are so many benefits for people, except pharmaceutical companies can't profit heavily from these drugs - yet.
- >> NEXT STORY: Netflix users can now download content to watch offline
- << PREVIOUS STORY: 12nm coming soon, uses 50% less power, can be 15% faster